CompletedPhase 4NCT05155436
Occurrence of Dyskalemia With Treatment for Hypertension
Studying Pseudohypoaldosteronism type 2
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National Heart Foundation of Bangladesh
- Principal Investigator
- Fazilatunnesa Malik, MBBS, FCPSNational Heart Foundation, Bangladesh
- Intervention
- Fixed Dose Combination pill of Telmisartan 40mg and Amlodipine 5 mg(drug)
- Enrollment
- 1090 enrolled
- Eligibility
- 40 years · All sexes
- Timeline
- 2022 – 2023
Study locations (1)
- National Heart Foundation of Bangladesh, Dhaka, Bangladesh
Collaborators
National Heart Foundation Hospital and Research Institute of Bangladesh · Johns Hopkins University · Resolve to Save Lives
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05155436 on ClinicalTrials.gov